XML 77 R66.htm IDEA: XBRL DOCUMENT v3.21.2
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2021
Sep. 25, 2021
USD ($)
Mar. 27, 2021
USD ($)
payment
Sep. 26, 2020
USD ($)
Sep. 25, 2021
USD ($)
Sep. 26, 2020
USD ($)
Jun. 26, 2021
USD ($)
Dec. 26, 2020
USD ($)
Dec. 28, 2019
USD ($)
Dec. 29, 2018
USD ($)
Debt Instrument [Line Items]                    
Weighted average interest rate   2.65%     2.65%     3.11%    
Deferred financing costs expensed         $ 38,253,000 $ 0        
Debt extinguishment and financing costs         $ 28,972,000 2,759,000        
Number of consecutive fiscal quarters         1 year          
Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Derivative amount   $ 400,000,000   $ 400,000,000 $ 400,000,000 400,000,000        
Term Loans                    
Debt Instrument [Line Items]                    
Prepayments of long-term debt     $ 146,900,000              
Deferred financing costs expensed     200,000              
Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Prepayments of long-term debt     135,000,000              
$750 Million Term Loan | Credit Facility                    
Debt Instrument [Line Items]                    
Credit facility     $ 750,000,000              
Number of quarterly installment payments | payment     19              
$2.05 Billion Credit Facility | Credit Facility                    
Debt Instrument [Line Items]                    
Minimum EBITDA less capital expenditures to consolidated cash interest expense ratio   3.50     3.50          
$2.05 Billion Credit Facility | Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Credit facility     $ 2,050,000,000.00              
5.5% Senior Notes due 2026 | Senior Notes                    
Debt Instrument [Line Items]                    
Prepayments of long-term debt     500,000,000              
Deferred financing costs expensed     5,000,000              
Aggregate principal amount                   $ 500,000,000
Stated interest rate   5.50%     5.50%     5.50%   5.50%
Debt extinguishment and financing costs     21,000,000              
Payments for accrued interest     13,000,000              
4.25% Senior Notes due 2028 | Senior Notes                    
Debt Instrument [Line Items]                    
Maximum consolidated indebtedness to consolidated EBITDA   4.25     4.25          
Aggregate principal amount                 $ 500,000,000  
Stated interest rate   4.25%     4.25%     4.25% 4.25%  
3.75% Senior Notes due 2029 | Senior Notes                    
Debt Instrument [Line Items]                    
Aggregate principal amount     $ 500,000,000              
Stated interest rate   3.75% 3.75%   3.75%     3.75%    
4.0% Senior Notes due 2031 | Senior Notes                    
Debt Instrument [Line Items]                    
Aggregate principal amount     $ 500,000,000              
Stated interest rate   4.00% 4.00%   4.00%     4.00%    
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Credit facility             $ 3,000,000,000      
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility | Federal Funds Rate                    
Debt Instrument [Line Items]                    
Variable interest rate 0.50%                  
$3 Billion Credit Facility | Credit Facility | Revolving Credit Facility | LIBOR                    
Debt Instrument [Line Items]                    
Variable interest rate 1.00%                  
Senior Notes Due 2029 And 2031 | Senior Notes                    
Debt Instrument [Line Items]                    
Aggregate principal amount     $ 1,000,000,000              
Debt extinguishment and financing costs     10,000,000              
Senior Notes Due 2029 And 2031 | Senior Notes | Cognate BioServices, Inc.                    
Debt Instrument [Line Items]                    
Debt extinguishment and financing costs     21,000,000              
Payments for accrued interest     $ 13,000,000              
Letter of Credit                    
Debt Instrument [Line Items]                    
Letters of credit outstanding   $ 16,700,000     $ 16,700,000     $ 16,000,000    
Other Nonoperating Income (Expense) | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Foreign currency losses recognized         22,700,000 4,200,000        
Interest Expense | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Recognized gains from derivatives   $ 5,048,000   $ 0 $ 24,380,000 $ 6,067,000